Heart failure ranks among the fastest-growing cardiovascular issues globally and leads to many hospital admissions in India. Unlike a sudden heart attack, it is a long-term condition needing ongoing care. Patients frequently face repeated symptom flare-ups that result in readmissions.
A recent U.K. trial showed that certain patients with worsening heart failure could safely manage diuretic treatment at home via a wearable pump after hospital stabilization, enabling earlier discharge without harming results.
The device, called Furosex, administers furosemide through a wearable infusion system. Patients who develop fluid overload after leaving hospital often need readmission for intravenous diuretics.
Balamurugan S., an interventional cardiologist at SRM Prime Hospital in Chennai, notes these innovations may apply in India. Heart failure requires chronic management, and avoiding readmissions matters greatly. In selected stable cases, such devices could cut readmissions, boost comfort and reduce costs.
Although not yet standard in India, cardiologists see a shift toward advanced drugs, remote monitoring, device therapies and artificial intelligence in heart failure care.
Treatment has evolved over the past decade. Earlier focus was mainly on easing symptoms, but current therapies improve survival and lower admissions, says Rajeev Thillak Chellasamy, a heart failure surgeon at SIMS Hospital in Chennai.
Guideline-directed medical therapy marks a key advance. Newer drugs target the disease process rather than just symptoms. Standard treatment now includes beta blockers, renin-angiotensin system inhibitors such as ACE inhibitors, ARBs and ARNIs, mineralocorticoid receptor antagonists and SGLT2 inhibitors.
Vericiguat, a soluble guanylate cyclase stimulator, offers another option for patients recovering from worsening episodes. P. Manokar of Kauvery Hospital in Chennai calls it the fifth pillar of therapy, noting it reduces repeat admissions in high-risk patients.
Medicines alone do not halt progression. Experts stress education on fluid and salt limits plus lifestyle adjustments to prevent further hospitalizations. Dedicated heart failure nurses could strengthen ongoing care in India.
Technology now allows remote monitoring after discharge. Smartwatches track heart rate, rhythm issues, oxygen levels and sometimes blood pressure or weight. These data can flag early signs of deterioration.
Subtle shifts like sudden weight gain or rising heart rate may signal congestion. The aim is early detection and intervention before emergencies arise. Wearables and telemedicine aid patients outside major cities with limited access to specialists.
The pandemic sped up remote monitoring adoption. Patients with implanted devices showed that data could be sent digitally, cutting hospital visits. Teleconsultations now bridge gaps for long-term management. Home-based wearable drug systems represent another development that may ease hospital pressure once scaled in India.
